Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-06-28 00:00:00 ET · period of report 2024-06-26 · accession 0000875320-24-000181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-28 | 2024-06-26 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $471.72 | -2,280 | 30.1K | -7% | -$1.08M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-26 | S | D | 2,280 | $471.72 | 30,099 | D | — | — |